In vivo hepatocellular expression of interleukin-22 using penetratin-based hybrid nanoparticles as potential anti-hepatitis therapeutics
about
In vivo hepatocellular expression of interleukin-22 using penetratin-based hybrid nanoparticles as potential anti-hepatitis therapeutics
description
im Oktober 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 03 October 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2018
@uk
name
In vivo hepatocellular express ...... al anti-hepatitis therapeutics
@en
In vivo hepatocellular express ...... al anti-hepatitis therapeutics
@nl
type
label
In vivo hepatocellular express ...... al anti-hepatitis therapeutics
@en
In vivo hepatocellular express ...... al anti-hepatitis therapeutics
@nl
prefLabel
In vivo hepatocellular express ...... al anti-hepatitis therapeutics
@en
In vivo hepatocellular express ...... al anti-hepatitis therapeutics
@nl
P2093
P1433
P1476
In vivo hepatocellular express ...... al anti-hepatitis therapeutics
@en
P2093
Chuzhen Yin
Dianwen Ju
Jiajun Fan
Jingyun Luan
Ming-Lin Liu
Shaofei Wang
Wenjing Zai
Xuyao Zhang
Yanxu Liang
P356
10.1016/J.BIOMATERIALS.2018.09.046
P407
P50
P577
2018-10-03T00:00:00Z